Shareholders Equity: The sum of preferred and common equity items.
MBX Biosciences, Inc. (MBX) had Shareholders Equity of $369.22M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-22.06M |
|
-- |
|
-- |
|
$25.80M |
|
$-25.80M |
|
$3.73M |
|
$-22.06M |
|
$-22.06M |
|
$-22.06M |
|
$-22.06M |
|
$-22.06M |
|
$-22.06M |
|
$-25.80M |
|
$-25.73M |
|
36.51M |
|
36.51M |
|
$-0.46 |
|
$-0.46 |
|
| Balance Sheet Financials | |
$381.54M |
|
$2.73M |
|
$3.60M |
|
$385.14M |
|
$15.49M |
|
-- |
|
$0.43M |
|
$15.92M |
|
$369.22M |
|
$369.22M |
|
|
Shareholders Equity |
$369.22M |
44.93M |
|
| Cash Flow Statement Financials | |
$-79.95M |
|
$-83.70M |
|
$189.59M |
|
$49.35M |
|
$75.29M |
|
$25.94M |
|
$8.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
24.62 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-81.88M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-5.98% |
|
-5.98% |
|
-5.73% |
|
-5.98% |
|
$8.22 |
|
$-2.24 |
|
$-2.19 |
|